Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | ADH1B | P00325 | 1/20 | 0.41 |
| ▸ | ADH1C | P00326 | 1/20 | 0.41 |
| ▸ | ADH1A | P07327 | 1/20 | 0.41 |
| ▸ | ADH4 | P08319 | 1/20 | 0.41 |
| ▸ | ADH7 | P40394 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.37 |
| ▸ | FAAH | O00519 | 2/20 | 0.37 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28099993 | 1.00 | LMNA (0.48) | LMNATSHRADH1BADH1CADH1A | |
| SCHEMBL9353669 | 1.00 | LMNA (0.48) | LMNATSHRADH1BADH1CADH1A | |
| SCHEMBL28100038 | 1.00 | LMNA (0.48) | LMNATSHRADH1BADH1CADH1A | |
| SCHEMBL11250959 | 1.00 | LMNA (0.48) | LMNATSHRADH1BADH1CADH1A | |
| SCHEMBL21834201 | 1.00 | LMNA (0.48) | LMNATSHRADH1BADH1CADH1A | |
| SCHEMBL28100022 | 1.00 | LMNA (0.48) | LMNATSHRADH1BADH1CADH1A | |
| SCHEMBL4259630 | 1.00 | LMNA (0.48) | LMNATSHRADH1BADH1CADH1A | |
| SCHEMBL17963049 | 1.00 | LMNA (0.48) | LMNATSHRADH1BADH1CADH1A | |
| SCHEMBL28100019 | 0.98 | LMNA (0.46) | LMNATSHRADH1BADH1CADH1A | |
| SCHEMBL27953212 | 0.98 | LMNA (0.46) | LMNATSHRADH1BADH1CADH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012065971-A9 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE ELASTOMERIC POLYURETHANE AND AT LEAST ONE CATIONIC POLYMER | L'OREAL (FR) | 2013-10-24 | — | — | WO | disclosed |
| US-20120128616-A1 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE ELASTOMERIC POLYURETHANE AND AT LEAST ONE CATIONIC POLYMER | L'OREAL S.A. (FR) | 2012-05-24 | — | — | US | disclosed |
| WO-2012065971-A2 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE ELASTOMERIC POLYURETHANE AND AT LEAST ONE CATIONIC POLYMER | L'OREAL (FR) | 2012-05-24 | — | — | WO | disclosed |
| EP-2432449-A2 | A COSMETIC COMPOSITION COMPRISING AT LEAST ONE ELASTOMERIC ANIONIC POLYURETHANE AND AT LEAST ONE NON-IONIC THICKENER | L'Oréal (FR) | 2012-03-28 | — | — | EP | disclosed |
| EP-2432448-A2 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE ELASTOMERIC POLYURETHANE | L'Oréal (FR) | 2012-03-28 | — | — | EP | disclosed |
| US-20100297051-A1 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE ELASTOMERIC ANIONIC POLYURETHANE AND AT LEAST ONE NON-IONIC THICKENER | L'OREAL S.A. (FR) | 2010-11-25 | — | — | US | disclosed |
| WO-2010133658-A2 | A COSMETIC COMPOSITION COMPRISING AT LEAST ONE ELASTOMERIC ANIONIC POLYURETHANE AND AT LEAST ONE NON-IONIC THICKENER | L'ORÉAL (FR) | 2010-11-25 | — | — | WO | disclosed |
| US-20100297052-A1 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE ELASTOMERIC POLYURETHANE | L'OREAL S.A. (FR) | 2010-11-25 | — | — | US | disclosed |
| WO-2010133660-A2 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE ELASTOMERIC POLYURETHANE | L'OREAL (FR) | 2010-11-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100297051-A1 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE ELASTOMERIC ANIONIC POLYURETHANE AND AT LEAST ONE NON-IONIC THICKENER | CUTA, DSG1, PARG | LMNA 2494/4885TSHR 1426/4885ADH1B 2858/4885 |
| US-20120128616-A1 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE ELASTOMERIC POLYURETHANE AND AT LEAST ONE CATIONIC POLYMER | CUTA, PUF60, PARN | LMNA 862/4885TSHR 2067/4885ADH1B 3781/4885 |
| US-20100297052-A1 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE ELASTOMERIC POLYURETHANE | CUTA, POLR1C, SUCLG1 | LMNA 1178/4885TSHR 3008/4885ADH1B 3056/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.